FDG-PET/CT scan to guide treatment for heart valve infection
Part of Heart & circulation clinical trials.
This study tests whether an FDG-PET/CT scan (a special imaging test) can help doctors choose the best treatment plan for people with a suspected native heart valve infection. It may help reduce uncertainty by showing where the infection activity is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and can give informed consent.
- You have been referred for an FDG-PET/CT scan.
- Before the scan, your doctors have labeled your condition as “possible” native valve infective endocarditis.
- You can physically and practically manage the PET/CT scan (lying still, following scan instructions).
- You do not have an artificial (prosthetic) heart valve or any implanted heart device (like a pacemaker/ICD).
- You are not pregnant and not breastfeeding, and your body mass index (BMI) is 45 or less.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an observational study that follows people with confirmed infective endocarditis (a serious infection of the heart lining or heart valves). It may help doctors better understand the illness and improve care.
This trial measures how your body handles certain intravenous antibiotics used for endocarditis, an infection of the heart valves. It may help doctors understand the best antibiotic dosing for people with valve infections.
This trial tests whether a special patient education program helps produce clearer heart PET scan images when checking for heart inflammation or infection. The program teaches patients how to follow a special diet and preparation steps before the scan.
This trial tests whether a treatment without rifampin works as well as one with rifampin for a type of heart valve infection caused by staph bacteria. It aims to find a simpler and safer option for patients with an infected artificial heart valve.
This study tests a new way to find the cause of infective endocarditis, a serious heart infection. It may help doctors choose the right treatment faster.
This trial tests a new imaging tracer called folate PET to see if it can help diagnose two heart conditions: cardiac sarcoidosis (inflammation in the heart) and infective endocarditis (infection on heart valves). If successful, it could offer a more accurate and targeted way to spot these problems early.
Hear when a new Infective Endocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.